Jo Anne Zujewski

2.3k total citations · 1 hit paper
23 papers, 1.3k citations indexed

About

Jo Anne Zujewski is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jo Anne Zujewski has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jo Anne Zujewski's work include Global Cancer Incidence and Screening (8 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). Jo Anne Zujewski is often cited by papers focused on Global Cancer Incidence and Screening (8 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). Jo Anne Zujewski collaborates with scholars based in United States, Canada and Peru. Jo Anne Zujewski's co-authors include Edith A. Perez, Julie R. Gralow, Priya Rastogi, Vera J. Suman, Nancy E. Davidson, Eric P. Winer, E. Mamounas, Charles E. Geyer, Silvana Martino and Edward H. Romond and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jo Anne Zujewski

23 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

2014 671 citations Edith A. Perez, Edward H. Romond et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jo Anne Zujewski United States	14	1.1k	461	380	233	216	23	1.3k
Vernon Harvey New Zealand	22	1.3k 1.2×	489 1.1×	312 0.8×	357 1.5×	258 1.2×	44	1.8k
Mariantonietta Colozza Italy	19	1.0k 0.9×	472 1.0×	233 0.6×	304 1.3×	360 1.7×	36	1.4k
Ingvil Mjaaland Norway	20	885 0.8×	822 1.8×	239 0.6×	369 1.6×	302 1.4×	43	1.6k
Raquel Nunes United States	14	816 0.8×	333 0.7×	303 0.8×	164 0.7×	171 0.8×	38	1.1k
Miguel Ángel Seguí Spain	22	889 0.8×	444 1.0×	124 0.3×	228 1.0×	267 1.2×	83	1.4k
José Luís Passos‐Coelho Portugal	21	913 0.9×	281 0.6×	179 0.5×	288 1.2×	273 1.3×	46	1.4k
Mauro Mansutti Italy	16	1.1k 1.0×	713 1.5×	185 0.5×	331 1.4×	187 0.9×	43	1.5k
Stella Dolci Belgium	12	847 0.8×	488 1.1×	250 0.7×	118 0.5×	277 1.3×	27	1.1k
Mohammad Jahanzeb United States	17	960 0.9×	390 0.8×	198 0.5×	547 2.3×	356 1.6×	32	1.5k
Chantal Bernard-Marty Belgium	14	845 0.8×	441 1.0×	191 0.5×	247 1.1×	280 1.3×	22	1.2k

Countries citing papers authored by Jo Anne Zujewski

Since Specialization

Citations

This map shows the geographic impact of Jo Anne Zujewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Anne Zujewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Anne Zujewski more than expected).

Fields of papers citing papers by Jo Anne Zujewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Anne Zujewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Anne Zujewski. The network helps show where Jo Anne Zujewski may publish in the future.

Co-authorship network of co-authors of Jo Anne Zujewski

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Anne Zujewski. A scholar is included among the top collaborators of Jo Anne Zujewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Anne Zujewski. Jo Anne Zujewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gralow, Julie R., et al.. (2021). Advancing Breast Cancer Advocacy in Eastern Europe and Central Asia: Findings From Women’s Empowerment Cancer Advocacy Network (WE CAN) Summits. JCO Global Oncology. 7(7). 585–592. 4 indexed citations

2.

Cira, Mishka Kohli, et al.. (2020). Promoting evidence-based practices for breast cancer care through web-based collaborative learning. Journal of Cancer Policy. 25. 100242–100242. 5 indexed citations

3.

Dvaladze, Allison, Anna Cabanes, Gertrude Nakigudde, et al.. (2020). Breast cancer patient advocacy: A qualitative study of the challenges and opportunities for civil society organizations in low‐income and middle‐income countries. Cancer. 126(S10). 2439–2447. 13 indexed citations

4.

Sayed, Shahin, Anthony Ngugi, Megan Mahoney, et al.. (2019). Breast Cancer knowledge, perceptions and practices in a rural Community in Coastal Kenya. BMC Public Health. 19(1). 180–180. 36 indexed citations

5.

Cira, Mishka Kohli, Jo Anne Zujewski, Allison Dvaladze, Nathan Brand, & Amanda L. Vogel. (2019). Knowledge Summaries for Comprehensive Breast Cancer Control: Feedback From Target Audiences in Kenya. Journal of Global Oncology. 5(5). 1–6. 5 indexed citations

6.

Otero, Isabel V., et al.. (2017). Building a Network of Health Professionals for Breast and Cervical Cancer Control in the Andean Region. Journal of Global Oncology. 4(4). 1–8. 4 indexed citations

7.

Zujewski, Jo Anne, Allison Dvaladze, André Ilbawi, et al.. (2017). Knowledge Summaries for Comprehensive Breast Cancer Control. Journal of Global Oncology. 4(4). 1–7. 16 indexed citations

8.

Orem, Jackson, et al.. (2016). Exploring stigma as a barrier to cancer service engagement with breast cancer survivors in Kampala, Uganda. Psycho-Oncology. 25(10). 1206–1211. 76 indexed citations

9.

Perez, Edith A., Edward H. Romond, Vera J. Suman, et al.. (2014). Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831. Journal of Clinical Oncology. 32(33). 3744–3752. 671 indexed citations breakdown →

10.

Piccart, Martine, Andrew Holmes, José Baselga, et al.. (2014). First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L), or their combination (T+L) in the adjuvant treatment of HER2-positive early breast cancer (EBC).. Journal of Clinical Oncology. 32(18_suppl). LBA4–LBA4. 101 indexed citations

11.

Lee, Jung Min, John L. Hays, Christina M. Annunziata, et al.. (2014). Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses. JNCI Journal of the National Cancer Institute. 106(6). dju089–dju089. 145 indexed citations

12.

Piccart, Martine, Andrew Holmes, José Baselga, et al.. (2014). First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L), or their combination (T+L) in the adjuvant treatment of HER2-positive early breast cancer (EBC).. Journal of Clinical Oncology. 32(15_suppl). LBA4–LBA4. 21 indexed citations

13.

Dueck, Amylou C., David W. Hillman, Lisa A. Kottschade, et al.. (2014). Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D).. Journal of Clinical Oncology. 32(15_suppl). 647–647. 3 indexed citations

14.

Andreopoulou, Eleni, Jo Anne Zujewski, Kevin Kalinsky, et al.. (2011). Randomized, double-blind, placebo-controlled phase II trial of low-dose metronomic cyclophosphamide alone or in combination with veliparib (ABT-888) in chemotherapy-resistant ER and/or PR-positive, HER2/neu-negative metastatic breast cancer: New York Cancer Consortium trial P8853.. Journal of Clinical Oncology. 29(15_suppl). TPS114–TPS114. 2 indexed citations

15.

Korde, Larissa A., Ashley Wilder Smith, David Venzon, et al.. (2009). Recruitment to a physical activity intervention study in women at increased risk of breast cancer. BMC Medical Research Methodology. 9(1). 27–27. 12 indexed citations

16.

Eng‐Wong, Jennifer, James C. Reynolds, David Venzon, et al.. (2006). Effect of Raloxifene on Bone Mineral Density in Premenopausal Women at Increased Risk of Breast Cancer. The Journal of Clinical Endocrinology & Metabolism. 91(10). 3941–3946. 20 indexed citations

17.

Yao, Jianhua, et al.. (2005). Classification and calculation of breast fibroglandular tissue volume on SPGR fat suppressed MRI. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 5747. 1942–1942. 25 indexed citations

18.

Saif, Muhammad Wasif, Susan F. Leitman, Georgie Cusack, et al.. (2004). Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer. Annals of Oncology. 15(9). 1366–1372. 7 indexed citations

19.

Eng‐Wong, Jennifer, Stephen D. Hursting, David Venzon, Susan N. Perkins, & Jo Anne Zujewski. (2003). Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.. PubMed. 12(12). 1468–73. 17 indexed citations

20.

Tolcher, Anthony W., Kenneth H. Cowan, Marianne Noone, et al.. (1996). Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients.. Journal of Clinical Oncology. 14(1). 95–102. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact